NEWS

Taiwan Bio Therapeutics and TRACT Therapeutics Announce Successful Transfer of TRACT’s Regulatory T Cell Platform Technology to Taiwan Bio’s Manufacturing Facility

August 12, 2024 08:00 AM Eastern Daylight Time TAIPEI, Taiwan & CHICAGO--Taiwan Bio Therapeutics, Inc. and TRACT Therapeutics, Inc. are...

Aug 12, 2024

[Chicago, IL and Taipei, Taiwan- 12Mar2024] - TRACT Therapeutics and Taiwan Bio Therapeutics are pleased to announce a poster...

Mar 12, 2024

[Chicago, IL and Taipei, Taiwan – 06Dec2023] – Taiwan Bio and TRACT Therapeutics are pleased to announce a new strategic partnership to...

Dec 6, 2023

TRACT Therapeutics, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company

Nov 19, 2020

SCIENTIFIC REPORTS, A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T Cells in Living Donor Kidney Transplants” April...

Sep 1, 2019